Ocugen, Inc. (OCGN) is having a phenomenal run in the year so far. Shares of the company have skyrocketed 209.6% year to date against the industry’s decline of 5.6%.The significant surge can be attributed to its encouraging pipeline progress.Ocugen is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines.Image Source: Zacks Investment ResearchThe company is developing a modifier gene therapy platform designed to fulfill the significant med ...